GoldenGolden
Advanced Search
BioInnovation Capital

BioInnovation Capital

A venture capital firm in Massachusetts that invests in businesses in the life science and healthcare-related sectors. 

BioInnovation Capital is a venture capital firm in Massachusetts, United States that invests in businesses in the life science and healthcare-related sectors. Founded in 2010 in Cambridge, Massachusetts, this company invests in early stage and late stage ventures. The company's notable investment portfolio includes Avexegen, Cereius, Epiodyne, Graphwear, Mitokinin, Nocion Therapeutics, Pandion Therapeutics, etc.

BioInnovation Capital is actively seeking new investments and as of December 2019, the company made a total of 7 investments in which 3 of them are lead investments.

Timeline

2010
Founded

Associated investment funds

People

Name
Role
LinkedIn

Eric W. Linsley

Managing General Partner

Anthony Walsh

Principal

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Cereius

Arkuda Therapeutics

Comet Therapeutics

GraphWear Technologies

Nocion Therapeutics

QurAlis

Vaxess Technologies

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.